Ohio State University Wexner Medical Center at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
Ohio State University Wexner Medical Center brings 4 presentations to ASH 2026 in New Orleans. Its program centres on autoimmune hemolytic anemia, sickle cell gene therapy and TP53 cancers. Work includes mycophenolate in warm autoimmune hemolytic anemia and expanding access to therapies for underserved groups.
| Organization | ASH 2026 Attendance |
|---|---|
Ohio State University Wexner Medical Center Columbus, OH | |
Academic medical center of The Ohio State University in Columbus. | Session Fri Dec 11 3:00pm–6:00pm Scientific Workshop on TP53: A Moving Target Mutations in the p53 gene bring a very poor outlook in myeloid cancers, and this workshop follows them from first mutation to therapy. Session Fri Dec 11 4:55pm–5:55pm Discovering Novel Therapeutics and Future Research Current and emerging treatments for p53-mutated disease, including immune approaches, resistance, and what separates responders from non-responders. Session Sat Dec 12 9:00am–9:25am Poster Sat Dec 12 5:30pm–7:30pm Poster Sun Dec 13 6:00pm–8:00pm Oral Mon Dec 14 4:30pm–6:00pm Poster Mon Dec 14 6:00pm–8:00pm |
Find decision makers at Ohio State University Wexner Medical Center
Tell us what you sell and we’ll find the people at Ohio State University Wexner Medical Center most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction